Outlook on the Flow Cytometry Global Market to 2026 - Key Drivers, Restraints and Opportunities
25 mai 2021 04h48 HE
|
Research and Markets
Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market Based on Technology, Product and Service, Application, End-User, and Geography - Global Forecast up to 2026" report has been added...
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period
06 mai 2021 16h05 HE
|
Fluidigm Corporation
Forecasting underlying base business growth of 16–17% supported by new product innovation SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an...
Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results
10 févr. 2021 16h05 HE
|
Fluidigm Corporation
Fourth Quarter Total Revenue Increased 38 Percent to $44.6 million Fourth Quarter Product and Service Revenue Increased 26 Percent to $40.5 million Full Year Total Revenue Increased 18 Percent to...
Global MRD (Minimal Residual Disease) Testing Market Report 2020-2025: One of the Most Rapidly Evolving and Dynamic Markets
22 janv. 2021 07h18 HE
|
Research and Markets
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2025" report has...
BennuBio Welcomes New COO
14 janv. 2021 12h55 HE
|
BennuBio
Albuquerque, NM, Jan. 14, 2021 (GLOBE NEWSWIRE) -- BennuBio—an Albuquerque, New Mexico-based biotechnology company—announces that Matthew Hess joined the company as Chief Operations Officer. ...
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
20 nov. 2020 21h54 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Completes Acquisition of InstruNor AS
26 févr. 2020 08h30 HE
|
Fluidigm Corporation
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. ...
Bioburden Testing Market To Reach USD 1.28 Billion By 2026 | Reports and Data
25 févr. 2020 11h00 HE
|
Reports and Data
New York, Feb. 25, 2020 (GLOBE NEWSWIRE) -- The global bioburden testing market is projected to grow at a CAGR of 12.7%, in terms of value, from 2016 to reach USD 1.28 billion by 2026. Bioburden...
Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System
09 déc. 2019 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm serving the life science tools market, recognized Fluidigm...
MEDIA ADVISORY - American Oncology Network, LLC (AON) celebrates new state-of-the-art Pathology Laboratory
25 sept. 2019 10h23 HE
|
American Oncology Network, LLC
Fort Myers, Fl., Sept. 25, 2019 (GLOBE NEWSWIRE) -- To serve its growing network of community-based oncology practices, American Oncology Network, LLC (AON) has doubled the size of its centralized...